Filed before 2025Filed 9 November 2023
Voltron Therapeutics, Inc. has sold $3.21M so far
Voltron Therapeutics, Inc., a biotech company based in New York, NY, has sold $3.21M so far in its equity round, according to a filing dated 9 November 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 9 November 2023
- First filed
- 9 November 2022
- Round
- Equity round (amended filing)
- Amount sold
- $3.21M
- Offering size
- Open-ended
- Investors so far
- 63
- Based in
- New York, NY
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 32% of the 1,396 tracked raises with an amount filed in 2023, and than 31% of the 142 in biotech.
Voltron Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 9 Nov 2023 | Amended filing | $3.21M | This raise |
| 9 Nov 2022 | New filing | $515K | This raise |
| 16 Jun 2022 | New filing | $300K | Another raise |
| 1 Sep 2021 | New filing | $2.5M | Another raise |
| 13 Jul 2021 | New filing | $3.35M | Another raise |
More with Lucius on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.